China Factory Provide CAS 179324-69-7 Bortezomib

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP
• State: Solid
• Purity: >99%
• Product Name: Bortezomib
• Model NO.: Bortezomib
• Extraction Type: Solvent Extraction
• Active Ingredient: Bortezomib
• Appearance: White Powder
• Test Method: HPLC
• Molecular Formula: C8h14MGO10
• Einecs No: 202-637-1
• Grade: Phamaceutical Grade
• Storage: Store in a Cool and Dry Place
• Free Sample: 10 Grams Available
• MOQ: 10 Grams
• Shipment: by FedEx DHL
• Stype: Pharmaceutical Raw Materials
• Shelf Life: 2 Years
• Transport Package: Drum
• Specification: 99% Min
• Trademark: Zebrago
• Origin: China
• HS Code: 2932999099
• Production Capacity: 1000kg/Year

Product Description

Bortezomib
It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting
the mammalian 26S proteasome, which is important in regulating the intracellular concentration of specific proteins
to maintain homeostasis within cells. The disruption of 26S proteasome function disrupts normal cellular homeostasis,
leading to cytotoxic effect on various kinds of cancer cells.
 

Product name	Bortezomib
CAS	179324-69-7
Appearance	white powder
Assay	99%
Storage	Cool and Protect from light

 

Bortezomib, a modified dipeptidyl boronic acid, is a therapeutic proteasome inhibitors used for the treatment of cancers. It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting the mammalian 26S proteasome, which is important in regulating the intracellular concentration of specific proteins to maintain homeostasis within cells. The disruption of 26S proteasome function disrupts normal cellular homeostasis, leading to cytotoxic effect on various kinds of cancer cells. 

1.Multiple myeloma
This product can be used in combination with melp halan and prednione (MP regimen) for the treatment of multiple myeloma patients who have not previously been treated and are not suitable for high-dose chemotherapy and myelosuppression; Or more than one treatment of relapsed patients with multiple myeloma.

2.Mantle cell lymphoma
This product can be used for the treatment of patients with relapsed or refractory mantle cell lymphoma. This patient received at least one treatment before using this product.
 

Certificate of Analysis

Batch Number		Z20190412001
Production Date		2019.04.12
Batch Quantity		80 KGS
Item	Test Standard		Testing Result
Appearance	Powder		Complies
Color	white Powder		Complies
Particle Size	100% pass 80 mesh		Complies
Oder	Characteristic		Complies
Taste	Characteristic		Complies
Loss on Drying	≤5.0%		2.20%
Residue on Ignition	≤0.1%		0.05%
Residual acetone	≤0.1%		Complies
Residual Ethanol	≤0.5%		Complies
Heave Mentals	≤10ppm		Complies
Na	≤0.1%		<0.1%
Pb	≤3 ppm		Complies
Total Plate	<1000CFU/g		Complies
Yeast & Mold	<100 CFU /g		Complies
E. Coli	Negative		Complies
Salmonella	Negative		Complies
Conclusion: Conform with USP Standard

Storage:Closed container. dry & cool. keep away from moisture &strong light
Shelf life:24 Months  

 

Shipping Options as follows
 

EMS	Around 7-10 working days
DHL	Around 3-5 working days
Fedex	Around 4-6 working days
TNT	Around 6-7 working days
By Air	Around 5-7 working days
By Sea	Around 15-30 working days

     

Perfect After-Sales Service

1. Product Pictures Showing
2. Shipment Tracking Number
3. Promptly Following Tracking Status
4. Delivery Notice
5. Product Quality Following
6. Product Feedback
7. Follow-up Improvement Suggestion

FAQ